Sector pending / Health ServicesUpdated 2026-05-10 22:07 UTC

FRA/CVS stock hub

FRA/CVS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/CVSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

98.2B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/CVS

In the news

Latest news · FRA/CVS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.9

P25 n/aP50 n/aP75 n/a

Trailing P/E38.6

P25 n/aP50 n/aP75 n/a

ROE3.8

P25 n/aP50 n/aP75 n/a

ROIC6.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/CVS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

234

Groups with data

Currency

USD

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	300,000
Employees Change	0%
Employees Change Percent	0
Enterprise value	EUR 154.8B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Health Services
Last refreshed	2026-05-10
Market cap	EUR 98.2B
Price	EUR 75.78
Price currency	EUR
Rev Per Employee	1,355,655.07x
Sic	8000
Symbol	fra/CVS
Website	https://www.cvshealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.59%
EV Earnings	60.89x
EV/EBIT	16.81x
EV/EBITDA	9.89x
EV/FCF	24.15x
EV/Sales	0.45x
FCF yield	6.53%
Forward P/E	11.86x
P/B ratio	1.46x
P/E ratio	38.6x
P/S ratio	0.28x
PE Ratio10 Y	23.11x
PE Ratio3 Y	36x
PE Ratio5 Y	30x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.67%
EBITDA Margin	3.8%
FCF margin	1.82%
Gross margin	13.39%
Gross Profit	EUR 47.1B
Gross Profit Growth	6.44%
Gross Profit Growth Q	8.46%
Gross Profit Growth3 Y	0.51%
Gross Profit Growth5 Y	2.25%
Net Income	EUR 2.5B
Net Income Growth	-44.47%
Net Income Growth Q	65.43%
Net Income Growth3 Y	-10.52%
Net Income Growth5 Y	-16.89%
Pretax Margin	0.85%
Profit Margin	0.72%
Profit Per Employee	EUR 9,799
ROA	2.67
Roa5y	3.25
ROCE	6.51
ROE	3.75
Roe5y	7.3
ROIC	6.3
Roic5y	6.76

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.05%
Cagr15y	10.39%
Cagr1y	33.56%
Cagr20y	8.24%
Cagr3y	9.78%
Cagr5y	5.05%
Div CAGR10	5.02%
Div CAGR3	0.95%
Div CAGR5	6.18%
EPS Growth	-45.23
EPS Growth Q	63.12
EPS Growth3 Y	-9.68
EPS Growth5 Y	-16.38
FCF Growth	24.46%
FCF Growth Q	-10.83%
FCF Growth3 Y	-24.81%
FCF Growth5 Y	-10.57%
OCF Growth	17.95%
OCF Growth Q	-6.74%
OCF Growth10 Y	1.54%
OCF Growth3 Y	-19.83%
OCF Growth5 Y	-7.73%
Revenue Growth	7.67x
Revenue Growth Q	6.15x
Revenue Growth3 Y	7.13x
Revenue Growth5 Y	8.47x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.6
Assets	EUR 219.4B
Cash	EUR 10.2B
Current Assets	EUR 63.4B
Current Liabilities	EUR 73.3B
Debt	EUR 67.9B
Debt EBITDA	EUR 4.25
Debt Equity	EUR 1.01
Debt FCF	EUR 10.6
Equity	EUR 67.3B
Interest Coverage	3.49
Liabilities	EUR 152.1B
Long Term Assets	EUR 156B
Long Term Liabilities	EUR 78.8B
Net Cash	EUR -57.7B
Net Cash By Market Cap	EUR -58.8
Net Debt EBITDA	EUR 4.32
Net Debt Equity	EUR 0.86
Net Debt FCF	EUR 9
Tangible Book Value	EUR -28.7B
Tangible Book Value Per Share	EUR -22.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.87
Inventory Turnover	19.99
Net Working Capital	EUR -16.4B
Quick ratio	0.61
Working Capital	EUR -10.1B
Working Capital Turnover	EUR -25.72

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.07%
Dividend Growth	-6.73%
Dividend Growth Years	0%
Dividend per share	EUR 2.28
Dividend Years	28
Dividend Yield	3%
Ex Div Date	2026-04-23
Last Dividend	EUR 0.57
Payout Frequency	Quarterly
Payout Ratio	116.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	11.01%
1Y total return	33.53%
200-day SMA	65.04
3Y total return	32.32%
50-day SMA	66.33
50-day SMA vs 200-day SMA	50over200
5Y total return	27.9%
All Time High	104.3
All Time High Change	-27.37%
All Time High Date	2022-08-16
All Time Low	10
All Time Low Change	657.8%
All Time Low Date	2003-01-31
ATR	1.49
Ch YTD	11.39
High	75.78
High52	75.78
High52 Date	2026-05-08
High52ch	0%
Low	74.28
Low52	50.27
Low52 Date	2025-07-25
Low52ch	50.75%
Ma50ch	14.25%
Price vs 200-day SMA	16.51%
RSI	72.35
RSI Monthly	59.04
RSI Weekly	64.76
Sharpe ratio	0.86x
Sortino ratio	1.39
Total Return	1.93%
Tr YTD	13.3
Tr15y	340.42%
Tr1m	14.05%
Tr1w	8.54%
Tr3m	19.73%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 9.4B
Operating Income Growth	16.19
Operating Income Growth Q	25.09
Operating Income Growth3 Y	-10.92
Operating Income Growth5 Y	-4.45
Operating margin	2.67

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,273,329,087%
Net Borrowing	-1,437,295,590
Shares Insiders	0.1%
Shares Institutions	89.95%
Shares Qo Q	0.16%
Shares Yo Y	1.07%
Short Ratio	2.31

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 5.8B
Average Volume	94.95x
Bv Per Share	52.77
CAPEX	EUR -2.5B
Ch10y	-18.28
Ch15y	201.1
Ch1m	13.07
Ch1w	8.54
Ch1y	28.86
Ch20y	218.9
Ch3m	18.7
Ch3y	17.85
Ch5y	8.47
Ch6m	11.29
Change	2.71%
Change From Open	2.02
Close	73.78
Days Gap	0.68
Depreciation Amortization	3,872,642,454
Dollar Volume	10,609.2
Earnings Date	2026-08-05
EBIT	EUR 9.4B
EBITDA	EUR 13.4B
EPS	EUR 1.99
F Score	6
FCF	EUR 6.4B
FCF EV Yield	4.14x
Financing CF	-4,272,319,800
Fiscal Year End	December
Founded	1,963
Goodwill	72,482,095,836
Graham Number	47.91844
Graham Upside	-36.77
Income Tax	EUR 480.5M
Investing CF	-5,189,055,900
Is Primary Listing	0
Last Earnings Date	2026-02-04
Last Report Date	2026-03-31
Last Split Date	2005-06-07
Last Split Type	Forward
Lynch Fair Value	EUR 9.82
Lynch Upside	-87.05
Ma150	66.88
Ma150ch	13.31%
Ma20	68.27
Ma20ch	11%
Net CF	-500,432,100
Next Earnings Date	2026-08-05
Open	74.28
P FCF Ratio	15.31
P OCF Ratio	10.95
Payment Date	2026-05-04
Position In Range	100
Ppne	23,554,688,436
Price Date	2026-05-08
Price EBITDA	EUR 7.34
Relative Volume	1.47x
Revenue	351,792,491,400x
SBC By Revenue	0.17x
Share Based Comp	585,427,500
Tax By Revenue	0.14x
Tax Rate	16.03%
Tr20y	387.62%
Tr6m	13.2%
Volume	140
Z Score	2.35

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/CVS dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.0%

$2.28 annual per share

Payout ratio

+116.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+6.2%

0 consecutive years of growth

Total shareholder yield

+1.9%

Next ex-dividend date: 2026-04-23

Performance

FRA/CVS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/CVS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+90.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/CVS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

72.4

Above 70: short-term overbought

Price vs 200-day MA

+16.5%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.86

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/CVS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/CVS stock rating?

fra/CVS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/CVS analysis?

The full report lives at /stocks/fra/CVS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/CVS?

The latest report frames fra/CVS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/CVS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.